ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2253

Racial Disparities in Total Shoulder Arthroplasty Utilization and Outcomes Are Persisting

Jasvinder A. Singh and Rekha Ramachandaran, University of Alabama at Birmingham, Birmingham, AL

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Arthroplasty, outcomes and race/ethnicity, Public Health Approach

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Epidemiology and Public Health Poster III (ACR): Gout and Non-Inflammatory Musculoskeletal Conditions

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

A recent study that used the 1993-2007 U.S. Nationwide Inpatient Sample (NIS) reported that Blacks had lower overall Total Shoulder Arthroplasty (TSA) utilization rates compared to Whites with a risk ratio of 0.6.  It is not known, whether the racial disparity in TSA utilization is increasing or decreasing in the U.S.  Our objective was to study whether racial disparities in total shoulder arthroplasty (TSA) utilization and outcomes have declined over time in the U.S.

Methods:

We used the U.S. Nationwide Inpatient Sample from 1998-2011.  We used chi-squared test to compare characteristics, Cochran-Armitage test to compare utilization rates, and Cochran-Armitage test and logistic regression to compare time-trends in outcomes by race. 

Results:

176,141 Whites and 7,694 Blacks underwent TSA from 1998-2011.  Compared to Whites, Blacks who underwent TSA were younger (69.1 vs. 64.2 years; p<0.0001) and more likely to be female (54.9% vs. 71.0%; p<0.0001), have rheumatoid arthritis or avascular necrosis as the underlying diagnosis (1.7% vs. 3.0% and 1.7% vs. 6.1 %; p<0.0001 for both) and Deyo-Charlson index of 2 or higher (8.5% vs. 16.7%; p<0.0001).  Compared to Whites, Blacks had much lower TSA utilization rate/100,000 in 1998 (2.97 vs. 0.83; p<0.0001) and in 2011 (12.27 vs. 3.33; p<0.0001); disparities increased from 1998 to 2011 (p<0.0001).  A higher proportion of Blacks than Whites had hospital stay greater than median in 1998-2000, 62% vs. 51.4% (p=0.02) and in 2009-2011, 27.3% vs. 34.4% (p<0.0001); disparities did not change over time (p=0.31).  These disparities were borderline significant in adjusted analyses.  There were no racial differences in proportion discharged to inpatient medical facility in 1998-2000, 15.2% vs. 15.0% (p=0.95) and in 2009-2011, 12.3% vs. 11.1% (p=0.37), respectively. 

Conclusion:

We found increasing racial disparities in TSA utilization. Some disparities in outcomes exist as well.  Patients, surgeons and policy-makes should be aware of these findings and take action to reduce racial disparities.


Disclosure: J. A. Singh, Takeda, Savient, 2,Takeda, Savient, merz, Regeneron, Allergan, Crealta, Bioiberica, 5; R. Ramachandaran, None.

To cite this abstract in AMA style:

Singh JA, Ramachandaran R. Racial Disparities in Total Shoulder Arthroplasty Utilization and Outcomes Are Persisting [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/racial-disparities-in-total-shoulder-arthroplasty-utilization-and-outcomes-are-persisting/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/racial-disparities-in-total-shoulder-arthroplasty-utilization-and-outcomes-are-persisting/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology